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Abstract 
Cerebellar Mutism Syndrome (CMS) is a well-described 
clinical entity that complicates surgeries for posterior fossa 
tumours; more so in children than adults. This review 
focuses on the current understanding of CMS, its incidence 
and risk factors. Incidence showed a variable range in 
retrospective studies due to variety of definitions. Risk 
factors can be classified as either modifiable including 
surgical technique, or non-modifiable which include 
tumour related factors. A positive correlation has been 
associated between tumour pathology, brain stem invasion 
and size of tumour at time of presentation with 
development of CMS.  
Keywords: Pediatric brain tumors, cerebellar mutism 
syndrome, posterior fossa syndrome 
Introduction 
Cerebellar mutism syndrome (CMS), often used 
interchangeably with posterior fossa syndrome (PFS), is not 
an uncommon complication, following surgical resection 
of tumours located in the cerebellum or fourth ventricle.1 
Cerebellar mutism was initially described as ‘akinetic 
mutism’ by Daly and Love in 1958 after the removal of a 
cerebellar tumour in a child. Historically, it comprised of 
complete loss of speech that was not associated with 
cranial nerve palsies, long tract signs or alteration of 
consciousness; and typically occurred within few hours to 
several days after posterior fossa tumour surgery.2 
However, CMS is now used to describe a broader clinical 
condition which comprises of transient speech impairment, 
decreased muscle tone, irritability, ataxia and psychosis 
mostly in children and young adults, usually following 
surgery for posterior fossa tumours.3  
The incidence of CMS has been reported in 8% to 32% 
children, however, there is significant discrepancy in this 
number because of high variability of definitions of CMS 
used by different authors.4 Patients show inconsistent 
recovery in a variable amount of time, with some regaining 
the lost function completely, but most having some 
residual dysarthria, ataxia or intellectual disability. CMS is 
commonly believed to be caused by destruction of the 
reciprocal cerebello-cerebral pathway and bilateral dentate 
nuclei. This disrupts dentate-thalamo-cerebral tract, which 
impairs corresponding areas of the cerebral cortex.4 Risk 
factors are mostly non-modifiable and include larger 
tumours (>5cm in diameter) located in the midline, 
brainstem invasion and pre-operative language deficits.4 It 
is commonly associated with medulloblastoma (40%), 
ependymomas (20%) and astrocytomas (15%).4 
Owing to advancement in surgical techniques, and early 
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Figure 1A: Pre-operative T1 post-contrast sagittal section of MRI brain of a 3 years 
old boy showing a homogenously contrast enhancing lesion in the posterior 
fossa, causing hydrocephalus and significant mass effect on brainstem. 
Figure 1B: PPost-operative T1 post-contrast sagittal section of MRI brain of the same 
patient showing resection cavity filled with fluid, and interval reduction in 
mass effect on brainstem and cerebellum as well as hydrocephalus. 
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diagnosis of posterior fossa tumours due to wider 
availability of magnetic resonance imaging (MRI), there has 
been an increase in posterior fossa surgeries and attempts 
for gross total resection, as one of the most important 
prognostic indicators in patients with posterior fossa 
tumours is extent of surgical resection. This theoretically 
increases the risk of developing CMS. Herein, we have 
reviewed the existing English language literature on CMS 
after surgical resection of posterior fossa brain tumours. 
Review of Evidence 
We searched ‘cerebellar mutism syndrome’, akinetic mutism’ 
and ‘posterior fossa syndrome’ on PubMed and Google 
scholar database. Despite a high reported incidence, the 
condition has not been very commonly studied. Robertson 
et al., published a large prospective multicenter study 
between 1994 and 2000, and studied 450 patients who had 
undergone craniotomy and resection of posterior fossa 
medulloblastoma.5 They reported incidence of CMS in 107 
patients (24%) within two months from surgery, and 
classified it into severe (43%), moderate (49%) and mild 
(8%) using a CMS survey that they had specifically designed 
for this study. The only significant risk factor with a positive 
correlation with CMS was brainstem invasion, whereas 
radical surgical resection was not a significant risk factor. 
They also found variable extent of recovery in most 
patients, but fewer patients attained complete recovery up 
to 1 year after surgery. Korah et al., in their retrospective 
series reviewed 63 children who had undergone surgical 
resection of medulloblastoma.6 Their median follow-up 
time was 7 years, and incidence of CMS was 29% (18 
patients). This study reported younger age, gross total 
resection, midline location of tumour and brainstem 
invasion to be statistically significant predictors of CMS.  
Another case series of 32 children who underwent 
resection of cerebellar tumours was published by Kotil et 
al., who reported the occurrence of CMS in 10 children 
(32%).7 They found larger tumour size and midline location 
to be significant risk factors for developing CMS. Although 
CMS or PFS have been predominantly described to occur 
in children, some cases in adults have also been reported. 
In 2019, Shamov et al., reported post-operative CMS in a 25 
years old female patient after resection of 4th ventricular 
medulloblastoma, which was the eighth such case in 
literature.8 They attributed excessive use of bipolar cautery 
and ultrasonic aspirator in close proximity to the 
cerebellum to be possible causes. 
Cobourn et al., had performed a retrospective review of 65 
patients who had undergone surgical resection of posterior 
fossa tumours at their center, and studied relation between 
important surgical steps and CMS.9 They reported 
incidence of CMS in 7 of their patients (10.8%) and found 
degree of cerebellar retraction and incision of vermis to be 
significant risk factors for CMS. In the light of their results, 
they recommended preference of telo-velar approach over 
trans-vermian approach for posterior fossa tumour 
resection. In another recent study, Dhaenens et al., had 
retrospectively reviewed MRI scans of 121 children with 
posterior fossa tumour who underwent surgery, and 
attempted to design and validate a preoperative risk 
prediction model for post-operative CMS.10 Twenty six 
percent of their patients had developed CMS. In their 
radiological risk prediction model they included Evan’s 
ratio, distance and angle between basilar artery and 
tumour and depth of invasion/compression and area of 
contact between brainstem and the tumour. Their 
proposed model had a sensitivity of 97% and specificity of 
84% in pre-operative prediction of CMS.10 
Conclusion  
The review of available literature shows CMS/PFS to be an 
important complication following posterior fossa tumour 
resection. Important modifiable risk factor may include 
surgical technique that avoids manipulation of vermis. 
However, more common factors responsible for this 
condition include tumour  location, pathology and size.  
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